Assembly Biosciences, Inc. Common Stock

ASMB US0453961080

💰
Capitalization
Small-cap

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

🔗
Website
Annual Performance 1
2021 2022 2023 2024 2025
-61% -47% -39% 58% 2%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
33
🙍
Insiders
7
Person Price Shares Total Published Completed
Bjorkquist Jeanette M
CCO 		9.85
USD 		180
Sold 		1,773
USD 		29/03/2025 31/03/2025
Mchutchison John G
 9.85
USD 		757
Sold 		7,455
USD 		31/03/2025 31/03/2025
White Nicole S
SR OFF 		9.85
USD 		197
Sold 		1,940
USD 		29/03/2025 31/03/2025
Okazaki Jason A
CEO 		9.85
USD 		355
Sold 		3,496
USD 		29/03/2025 31/03/2025
Houghton Michael
 15.61
USD 		3,202
Bought 		49,998
USD 		30/12/2024 30/12/2024
Gilead Sciences, Inc.
O 		21.37
USD 		940,499
Bought 		20,098,464
USD 		19/12/2024 19/12/2024
Schornstein Alexander
O 		15.00
USD 		2,976
Bought 		44,640
USD 		22/11/2024 25/11/2024
Schornstein Alexander
O 		14.85
USD 		5,000
Bought 		74,250
USD 		22/11/2024 25/11/2024
Schornstein Alexander
O 		14.87
USD 		17,024
Bought 		253,104
USD 		22/11/2024 22/11/2024
White Nicole S
SR OFF 		16.29
USD 		40
Sold 		652
USD 		18/11/2024 18/11/2024

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Assembly Biosciences, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-6% 16% 37% 35% -94% -95% -80%
Last 52W Low 52W High All-Time Low All-Time High β
23.86 8.26 26.93 7.77 769.92
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Gilead Sciences, Inc. 1 20,098,463.63 20,098,463.63 19/12/2024 19/12/2024
Schornstein Alexander 10 1,422,789.16 142,278.92 20/11/2023 25/11/2024
Okazaki Jason A 7 58,183.85 8,311.98 27/03/2024 31/03/2025
Mchutchison John G 3 54,834.57 18,278.19 01/04/2024 31/03/2025
Houghton Michael 1 49,997.63 49,997.63 30/12/2024 30/12/2024
White Nicole S 8 37,508.81 4,688.60 17/11/2023 31/03/2025
Bjorkquist Jeanette M 3 3,621.27 1,207.09 01/04/2024 31/03/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.